- CVS earnings rise despite no tobacco fix Updated: Aug-04-15 8:19 am
Pricey specialty drugs helped CVS Health cope with tobacco withdrawal to top analyst expectations in the second quarter.
- Lawsuit accuses CVS of overcharging for generic drugs Updated: Jul-30-15 9:50 pm
SAN FRANCISCO - CVS Health Corp. deliberately overcharged some pharmacy customers for generic drugs by submitting claims to their insurance companies at inflated prices, according to a lawsuit filed Thursday in federal court in San Francisco.
- New state budget comes with higher costs for MinnesotaCare Updated: Jul-30-15 3:34 pm
ST. PAUL, Minnesota - Minnesota lawmakers kept MinnesotaCare intact but not without a cost that will trickle down to some of the more than 100,000 low-income residents on the program in the form of higher monthly premiums starting in August.
- Health care spending to accelerate, US report says Updated: Jul-28-15 4:56 pm
WASHINGTON - The nation's respite from accelerating health care costs appears to be over.
- Covered California: Cost of health care coverage increasing Updated: Jul-27-15 9:16 pm
SACRAMENTO, California - The cost of private individual health plans on California's state-run market will increase about 4 percent for the second straight year, evidence the strategy of forcing insurers to compete is controlling costs, program officials said Monday.
- Israel's Teva buys Allergan generic drug company for $40.5B Updated: Jul-27-15 8:16 am
JERUSALEM - Israel's Teva Pharmaceutical Industries Ltd. said Monday it is purchasing Dublin-based Allergan PLC's generic pharmaceuticals business for $40.5 billion, in what Israeli analysts called the largest-ever acquisition by an Israeli company.
- FDA OKs breakthrough cholesterol drug for high-risk patients Updated: Jul-24-15 6:33 pm
WASHINGTON - The Food and Drug Administration on Friday approved a first-of-a-kind drug that lowers artery-clogging cholesterol more than older drugs that have been prescribed for decades.
- Bristol-Myers wins approval for 1st hepatitis C type 3 drug Updated: Jul-24-15 6:02 pm
TRENTON, New Jersey - An experimental drug for one of the hardest-to-treat types of hepatitis C has been approved by the Food and Drug Administration, adding to the surge of new options - all much more effective but extremely costly - for patients with the liver-destroying virus.
- Mega-health deals bloom in July, Anthem bids $48B for Cigna Updated: Jul-24-15 2:02 pm
NEW YORK - Anthem is buying rival Cigna for $48 billion in a deal that would create the nation's largest health insurer by enrollment, covering about 53 million U.S patients.
- Drug company agrees to pay for filling invalid prescriptions Updated: Jul-23-15 1:35 pm
LOUISVILLE, Kentucky - The U.S. attorney in Louisville says an Internet drug company has agreed to forfeit $450,000 from the illegal sale of prescription drugs as part of a guilty plea.
- On-demand doctor apps bring Uber approach to medicine Updated: Jul-22-15 5:38 pm
WASHINGTON - It was 8 o'clock on a weeknight and Brooklyn resident Sarah Sheehan was reeling from a painful earache.
- Court ruling clears way for Novartis' low-cost biotech drug Updated: Jul-21-15 3:56 pm
WASHINGTON - A federal appeals court has ruled that Novartis can begin selling its lower-cost copy of an Amgen Inc. drug in September, rejecting a bid to further delay the launch of the knock-off biotech medication.
- Europe approves Amgen's first-in-class cholesterol drug Updated: Jul-21-15 2:33 pm
WASHINGTON - Amgen on Tuesday received European approval for its first-of-a-kind cholesterol drug that lowers levels of the artery-clogging substance more than older drugs that have been prescribed for decades.
- Cost of insurance forcing many in Detroit to 'drive dirty' Updated: Jul-20-15 2:05 pm
DETROIT - Like most Americans, the drivers of Detroit are required to carry auto insurance whenever they get behind the wheel, but many law-abiding residents can't afford the Motor City's highest-in-the-nation auto premiums, which top $5,000 a year in some neighborhoods.
- Pricey successor overtakes $1,000-per-pill hepatitis C drug Updated: Jul-13-15 4:20 pm
WASHINGTON - The $1,000 pill for a liver-wasting viral infection that made headlines last year is no longer the favorite of patients and doctors.
- Drug testing sends Hancock Co. Youth Court over budget Updated: Jul-13-15 4:32 am
BAY ST. LOUIS, Mississippi - Hancock County Youth Court officials are scrambling to cover a $93,000 budget shortfall.
- New Hampshire health price website earns 'A' grade Updated: Jul-09-15 2:11 pm
CONCORD, New Hampshire - Two nonprofit groups pushing for health care reform give New Hampshire top marks when it comes to transparency in health care prices.